A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)

  • Navarro Holguin, Marcela (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/29/19 → 10/28/21

Funding

  • Merck Sharp and Cohme Corporation: $6,000.00